• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深入探讨 PHF20L1 启动子甲基化及其与乳腺癌转移的基因相关性。

An insight into the promoter methylation of PHF20L1 and the gene association with metastasis in breast cancer.

机构信息

Medical School, Graduate Section, National Polytechnic Institute, Mexico City, Mexico.

Department of Biomedicine, Faculty of Medicine, Meritorious Autonomous University of Puebla (BUAP), Puebla, Mexico.

出版信息

Adv Clin Exp Med. 2021 May;30(5):507-515. doi: 10.17219/acem/133426.

DOI:10.17219/acem/133426
PMID:33847474
Abstract

BACKGROUND

Plant homeodomain finger protein 20-like 1 (PHF20L1) is a protein reader involved in epigenetic regulation that binds monomethyl-lysine. An oncogenic function has been attributed to PHF20L1 but its role in breast cancer (BC) is not clear.

OBJECTIVES

To explore PHF20L1 promoter methylation and comprehensive bioinformatics analysis to improve understanding of the role of PHF20L1 in BC.

MATERIAL AND METHODS

Seventy-four BC samples and 16 control samples were converted using sodium bisulfite treatment and analyzed with methylation-specific polymerase chain reaction (PCR). Bioinformatic analysis was performed in the BC dataset using The Cancer Genome Atlas (TCGA) trough data visualized and interpreted in the MEXPRESS website. Methylation, gene expression and survival evaluation were performed with R v. 4.0.2 software. Using multiple bioinformatic tools, we conducted a search for genes co-expressed with PHF20L1, analyzed its ontology and predicted associated miRNAs and miRNA-PHF20L1 networks. The expression and prognostic value of PHF20L1 and co-expressed genes were analyzed.

RESULTS

We found demethylation in PHF20L1 promoter in both BC samples and healthy tissues. Data mining with 241 patients demonstrated changes in methylation of promoter regions in basal-like and luminal A subtypes. Expression of the PHF20L1 gene had a negative correlation with methylation. Twelve genes were co-expressed. PHF20L1 is a target of miR96-5p, miR9-5p and miR182-5p, which are involved in proliferation and metastasis. PHF20L1 gene expression was not associated with overall survival (OS), or relapse-free survival (RFS), but was associated with distant metastasis-free survival (DMFS).

CONCLUSIONS

Our findings showed differences in methylation of PHF20L1 promoter region near TSS and upstream in BC subtypes; its overexpression impacted DMFS. We found that PHF20L1 is targeted by miR96-5p, miR9-5p and miR182-5p, which are involved in proliferation and metastasis, and regulates genes engaged in processes such as alternative splicing.

摘要

背景

植物同源结构域指蛋白 20 样 1(PHF20L1)是一种参与表观遗传调控的蛋白阅读因子,可与单甲基化赖氨酸结合。PHF20L1 具有致癌功能,但在乳腺癌(BC)中的作用尚不清楚。

目的

探索 PHF20L1 启动子甲基化,并进行综合生物信息学分析,以提高对 PHF20L1 在 BC 中作用的认识。

材料与方法

采用亚硫酸氢盐处理将 74 例 BC 样本和 16 例对照样本进行转化,并用甲基化特异性聚合酶链反应(PCR)进行分析。利用 The Cancer Genome Atlas(TCGA)的转录组数据,在 MEXPRESS 网站上进行可视化和解释,在 BC 数据集进行生物信息学分析。采用 R v.4.0.2 软件进行甲基化、基因表达和生存评估。使用多种生物信息学工具,我们进行了与 PHF20L1 共表达基因的搜索,分析了它们的本体,并预测了相关的 miRNA 和 miRNA-PHF20L1 网络。分析了 PHF20L1 和共表达基因的表达和预后价值。

结果

我们发现 BC 样本和健康组织中 PHF20L1 启动子去甲基化。对 241 例患者进行的数据挖掘显示,基底样和管腔 A 型亚组中启动子区域的甲基化发生改变。PHF20L1 基因的表达与甲基化呈负相关。有 12 个基因共表达。PHF20L1 是 miR96-5p、miR9-5p 和 miR182-5p 的靶基因,这些 miRNA 参与增殖和转移。PHF20L1 基因表达与总生存期(OS)或无复发生存期(RFS)无关,但与无远处转移生存期(DMFS)有关。

结论

我们的研究结果表明,BC 亚型中 PHF20L1 启动子区域靠近 TSS 和上游的甲基化存在差异;其过表达影响 DMFS。我们发现,PHF20L1 是 miR96-5p、miR9-5p 和 miR182-5p 的靶基因,这些 miRNA 参与增殖和转移,并调节参与选择性剪接等过程的基因。

相似文献

1
An insight into the promoter methylation of PHF20L1 and the gene association with metastasis in breast cancer.深入探讨 PHF20L1 启动子甲基化及其与乳腺癌转移的基因相关性。
Adv Clin Exp Med. 2021 May;30(5):507-515. doi: 10.17219/acem/133426.
2
An integrated genomic analysis of Tudor domain-containing proteins identifies PHD finger protein 20-like 1 (PHF20L1) as a candidate oncogene in breast cancer.对含Tudor结构域蛋白的综合基因组分析确定了类PHD指蛋白20样1(PHF20L1)为乳腺癌中的一个候选癌基因。
Mol Oncol. 2016 Feb;10(2):292-302. doi: 10.1016/j.molonc.2015.10.013. Epub 2015 Oct 28.
3
DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.DNA甲基化导致12种癌症相关微小RNA的失调及乳腺癌进展。
Gene. 2017 Mar 10;604:1-8. doi: 10.1016/j.gene.2016.12.018. Epub 2016 Dec 18.
4
Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.下一代测序分析确定miR-574-3p和miR-660-5p为乳腺癌潜在的新型预后标志物。
BMC Genomics. 2015 Sep 29;16:735. doi: 10.1186/s12864-015-1899-0.
5
Methyllysine reader plant homeodomain (PHD) finger protein 20-like 1 (PHF20L1) antagonizes DNA (cytosine-5) methyltransferase 1 (DNMT1) proteasomal degradation.甲基赖氨酸读蛋白植物同源结构域(PHD)手指蛋白 20 样 1(PHF20L1)拮抗 DNA(胞嘧啶-5)甲基转移酶 1(DNMT1)蛋白酶体降解。
J Biol Chem. 2014 Mar 21;289(12):8277-87. doi: 10.1074/jbc.M113.525279. Epub 2014 Feb 3.
6
Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.卵巢癌中异常甲基化调控的新型 miRNA 基因参与转移。
Gene. 2018 Jul 1;662:28-36. doi: 10.1016/j.gene.2018.04.005. Epub 2018 Apr 6.
7
Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.微小RNA-29c在乳腺癌中的分子亚型特异性表达与启动子的CpG二核苷酸甲基化相关。
PLoS One. 2015 Nov 5;10(11):e0142224. doi: 10.1371/journal.pone.0142224. eCollection 2015.
8
Methyl-lysine readers PHF20 and PHF20L1 define two distinct gene expression-regulating NSL complexes.甲基赖氨酸阅读器 PHF20 和 PHF20L1 定义了两个不同的基因表达调控 NSL 复合物。
J Biol Chem. 2022 Mar;298(3):101588. doi: 10.1016/j.jbc.2022.101588. Epub 2022 Jan 14.
9
Methylation of the HOXA10 Promoter Directs miR-196b-5p-Dependent Cell Proliferation and Invasion of Gastric Cancer Cells.HOXA10 启动子的甲基化指导 miR-196b-5p 依赖的胃癌细胞增殖和侵袭。
Mol Cancer Res. 2018 Apr;16(4):696-706. doi: 10.1158/1541-7786.MCR-17-0655. Epub 2018 Feb 16.
10
PHF20L1 as a H3K27me2 reader coordinates with transcriptional repressors to promote breast tumorigenesis.PHF20L1 作为 H3K27me2 的读取蛋白,与转录抑制因子协同作用促进乳腺癌发生。
Sci Adv. 2020 Apr 15;6(16):eaaz0356. doi: 10.1126/sciadv.aaz0356. eCollection 2020 Apr.

引用本文的文献

1
PHF20L1: An Epigenetic Regulator in Cancer and Beyond.PHF20L1:癌症及其他领域的一种表观遗传调控因子
Biomolecules. 2025 Jul 18;15(7):1048. doi: 10.3390/biom15071048.
2
Applications of CRISPR-Cas9 in mitigating cellular senescence and age-related disease progression.CRISPR-Cas9在减轻细胞衰老和与年龄相关疾病进展方面的应用。
Clin Exp Med. 2025 Jul 8;25(1):237. doi: 10.1007/s10238-025-01771-3.
3
Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies.乳腺癌中的表观遗传学与环境:抗癌治疗的新范式
Front Oncol. 2022 Sep 15;12:971288. doi: 10.3389/fonc.2022.971288. eCollection 2022.
4
Diagnostic and Prognostic Performance of Liquid Biopsy-Derived Exosomal MicroRNAs in Thyroid Cancer Patients: A Systematic Review and Meta-Analysis.液体活检来源的外泌体微小RNA在甲状腺癌患者中的诊断和预后性能:一项系统评价和荟萃分析
Cancers (Basel). 2021 Aug 26;13(17):4295. doi: 10.3390/cancers13174295.